Jonathan Brett

1.8k total citations
80 papers, 1.1k citations indexed

About

Jonathan Brett is a scholar working on Psychiatry and Mental health, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jonathan Brett has authored 80 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 14 papers in Public Health, Environmental and Occupational Health and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jonathan Brett's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Schizophrenia research and treatment (11 papers) and Opioid Use Disorder Treatment (11 papers). Jonathan Brett is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Schizophrenia research and treatment (11 papers) and Opioid Use Disorder Treatment (11 papers). Jonathan Brett collaborates with scholars based in Australia, United States and United Kingdom. Jonathan Brett's co-authors include Bridin Murnion, Sallie‐Anne Pearson, Nicholas A. Buckley, Benjamin Daniels, Adam G. Elshaug, Richard O. Day, Kelsey Chalmers, Tim Badgery‐Parker, Jane E. Carland and Emily A. Karanges and has published in prestigious journals such as PLoS ONE, Pain and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Jonathan Brett

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Brett Australia	19	222	207	204	169	166	80	1.1k
Emily A. Karanges Australia	15	247 1.1×	361 1.7×	124 0.6×	133 0.8×	339 2.0×	30	1.3k
David Reith New Zealand	25	227 1.0×	255 1.2×	143 0.7×	187 1.1×	241 1.5×	124	2.0k
Elaine Chiquette United States	18	213 1.0×	329 1.6×	108 0.5×	115 0.7×	109 0.7×	38	1.8k
Fatemeh Yazdi Canada	23	288 1.3×	299 1.4×	162 0.8×	119 0.7×	438 2.6×	58	2.0k
Andrew I. Geller United States	19	126 0.6×	157 0.8×	162 0.8×	131 0.8×	286 1.7×	46	2.3k
Bridin Murnion Australia	19	164 0.7×	664 3.2×	132 0.6×	116 0.7×	419 2.5×	65	1.7k
Sunny A. Linnebur United States	22	157 0.7×	142 0.7×	225 1.1×	95 0.6×	165 1.0×	75	1.4k
Salahdein Aburuz Jordan	24	93 0.4×	188 0.9×	160 0.8×	165 1.0×	119 0.7×	103	1.8k
Johan J. de Gier Netherlands	20	89 0.4×	138 0.7×	184 0.9×	196 1.2×	127 0.8×	39	1.4k
Caroline Victorri‐Vigneau France	19	293 1.3×	203 1.0×	76 0.4×	52 0.3×	257 1.5×	138	1.3k

Countries citing papers authored by Jonathan Brett

Since Specialization

Citations

This map shows the geographic impact of Jonathan Brett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Brett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Brett more than expected).

Fields of papers citing papers by Jonathan Brett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Brett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Brett. The network helps show where Jonathan Brett may publish in the future.

Co-authorship network of co-authors of Jonathan Brett

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Brett. A scholar is included among the top collaborators of Jonathan Brett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Brett. Jonathan Brett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, N. R., et al.. (2026). Retention in opioid agonist treatment during pregnancy and variations according to treatment and maternal characteristics. Addiction.

Humphries, Chris, Michael Eddleston, Adam Lloyd, et al.. (2025). De-siloing substance misuse and self-harm research through integrated public health and emergency medicine. The Lancet Public Health. 10(8). e716–e721.

Carland, Jane E., et al.. (2025). A 3-year experience of an Australian short-stay Psychiatric, Alcohol and Non-prescription Drug Assessment Unit: unit activity and the patient experience. Emergency Medicine Journal. 43(1). 15–21.

Siefried, Krista J., Janette L. Smith, Jared A Brown, et al.. (2025). Emergency department presentations, hospitalisations and police seizure data related to gamma‐hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024. Addiction. 121(2). 305–315.

Brett, Jonathan, et al.. (2024). Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use. Frontiers in Psychiatry. 15. 1490907–1490907. 3 indexed citations

Siefried, Krista J., Angela L. Chiew, Nazila Jamshidi, et al.. (2024). Trends in reported GHB‐related presentations to Sydney emergency departments between 2012 and 2021. Emergency Medicine Australasia. 36(4). 604–608. 6 indexed citations

Koch, Forrest, Jake Olivier, Jonathan Brett, et al.. (2024). The impact of tightened prescribing restrictions for PBS‐subsidised opioid medicines and the introduction of half‐pack sizes, Australia, 2020–21: an interrupted time series analysis. The Medical Journal of Australia. 220(6). 315–322. 6 indexed citations

Bayes, Adam, Mark Montebello, Jonathan Brett, et al.. (2024). Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand. Australian & New Zealand Journal of Psychiatry. 58(10). 831–838. 5 indexed citations

Carland, Jane E., Jonathan Brett, Sophie L. Stocker, et al.. (2024). Economic evaluations of therapeutic drug monitoring interventions in acute hospital‐based settings: A systematic review. British Journal of Clinical Pharmacology. 90(9). 2038–2066.

10.

Cairns, Rose, Jacques Raubenheimer, Kate M. Chitty, et al.. (2024). Poisoning and envenomation linkage to evaluate outcomes and clinical variation in Australia (PAVLOVA): a longitudinal data-linkage cohort of acute poisonings, envenomations, and adverse drug reactions in New South Wales, Australia, 2011–2020. Clinical Toxicology. 62(10). 615–624.

11.

Carland, Jane E., Alexandra E. Stacy, Andrea L. Schaffer, et al.. (2023). Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin. British Journal of Clinical Pharmacology. 89(6). 1896–1902.

12.

Brett, Jonathan, M. Gillies, Nicholas A. Buckley, Sallie‐Anne Pearson, & Helga Zoëga. (2023). Patterns of suboptimal antipsychotic use and misuse in Australia: What can routinely collected data tell us?. British Journal of Clinical Pharmacology. 89(11). 3411–3420. 1 indexed citations

13.

Brett, Jonathan, et al.. (2023). Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications. Internal Medicine Journal. 53(7). 1284–1287. 2 indexed citations

14.

Black, Eleanor, Lauren A. Monds, Betty S. Chan, et al.. (2022). Overdose and take‐home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with ‘take‐home naloxone’ in emergency departments. Emergency Medicine Australasia. 34(4). 509–518. 7 indexed citations

15.

Siefried, Krista J., et al.. (2022). Barriers to help‐seeking among music festival attendees in New South Wales, Australia. Drug and Alcohol Review. 41(6). 1322–1330. 7 indexed citations

16.

Ezard, Nadine, Nicholas Lintzeris, Adrian Dunlop, et al.. (2022). Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal. PLoS ONE. 17(10). e0275371–e0275371. 4 indexed citations

17.

Siefried, Krista J., et al.. (2021). Correlates of higher‐risk drug‐related behaviours at music festivals in New South Wales, Australia. Drug and Alcohol Review. 41(2). 320–329. 11 indexed citations

18.

Brett, Jonathan, Krista J. Siefried, Mary Harrod, et al.. (2021). Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019–2020. Clinical Toxicology. 60(4). 440–445. 13 indexed citations

19.

Stocker, Sophie L., Jane E. Carland, Stephanie E. Reuter, et al.. (2020). Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis. Clinical Pharmacology & Therapeutics. 109(1). 212–221. 18 indexed citations

20.

Chalmers, Kelsey, Sallie‐Anne Pearson, Tim Badgery‐Parker, et al.. (2019). Measuring 21 low-value hospital procedures: claims analysis of Australian private health insurance data (2010–2014). BMJ Open. 9(3). e024142–e024142. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact